Two new monographs published in the European Paediatric Formulary
Further to their approval by the Ph. Eur. Commission and adoption by the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH), two new monographs, Clonidine hydrochloride 10 micrograms/mL oral solution and Furosemide 2 mg/mL oral solution, have been published in the European Paediatric Formulary (February 2024). Additional information is available on the EDQM website.
Users can register for free access to the Pharmeuropa PaedForm platform. For more information on how to create your account or use the website, please consult the User manual.
About the European Paediatric Formulary This menu provides access to the texts of the European Paediatric Formulary. These include final texts, drafts for public consultation and discontinued texts which will be available in an archive.
The European Paediatric Formulary is a freely available, pan-European collection of formulations for extemporaneous preparations that are currently described in national formularies and formulations which are already well-established in European countries. The aim is to give pharmacists and clinicians access to formulations of appropriate quality, allowing preparation of a medicinal product when no licensed alternative is available on the market. The project was launched by the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH) and the European Pharmacopoeia Commission (for which the EDQM provides the scientific secretariats). The Formulary is intended to be a user-friendly, science-based online tool providing access to a collection of child-appropriate formulations.
Draft texts for public consultation Preliminary drafts of new and revised texts for inclusion in the European Paediatric Formulary can be found under Pharmeuropa PaedForm.
How to consult the European Paediatric Formulary
How to access An account with a valid e-mail address is necessary to access the data. Please register via the button at the top of the page.